Options. They are what every oncologist and cancer patient wants. From treatments to diagnostic procedures, options represent a mixed bag of hope, risks, pain and costs, to name a few. But what if we could offer an option that promised to show doctors information regarding cancer evolution more frequently, without the complications and challenges of biopsy or imaging? To see how cancer is changing and evolving in response to treatment—real, quantitative data—from a simple urine or blood test. Giving physicians complete control to treat, monitor, and adjust as they deem necessary, for virtually any patient, in almost any circumstance.
This is the promise that drives us. This is the promise of Trovagene Precision Cancer Monitoring.